Advertisment

Pharmaceuticals firm Lupin

Lupin Pharma
Pharmaceuticals firm Lupin Ltd on Thursday said it has received approval from the US health regulator to market its generic rufinamide tablets used in the treatment seizures. The
Advertisment
Subscribe